[144] AGILENT TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

Agilent Technologies (A) filed a Form 14411/26/2025464,956.00283,500,427

The shares to be sold were acquired over time through employee stock purchase plan (ESPP) purchases made for cash and through restricted stock that vested as compensation between 10/31/202211/22/2024

11/26/2025 - 02:26 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	464956.00	283500427	11/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/31/2022	ESPP Purchase	Issuer			69	10/31/2022	Cash
Common	04/28/2023	ESPP Purchase	Issuer			128	04/28/2023	Cash
Common	11/14/2023	Restricted Stock Vesting	Issuer			289	11/14/2023	Compensation
Common	11/15/2023	Restricted Stock Vesting	Issuer			185	11/15/2023	Compensation
Common	11/16/2023	Restricted Stock Vesting	Issuer			143	11/16/2023	Compensation
Common	11/17/2023	Restricted Stock Vesting	Issuer			187	11/17/2023	Compensation
Common	04/30/2024	ESPP Purchase	Issuer			121	04/30/2024	Cash
Common	11/15/2024	Restricted Stock Vesting	Issuer			185	11/15/2024	Compensation
Common	11/16/2024	Restricted Stock Vesting	Issuer			143	11/16/2024	Compensation
Common	11/17/2024	Restricted Stock Vesting	Issuer			186	11/17/2024	Compensation
Common	11/19/2024	Restricted Stock Vesting	Issuer			1107	11/19/2024	Compensation
Common	11/22/2024	Restricted Stock Vesting	Issuer			257	11/22/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Agilent Technologies (A) disclose in this Form 144 filing?

The filing discloses a planned sale of 3,000 shares of Agilent Technologies common stock, with an aggregate market value of 464,956.00, to be sold on the NYSE through Fidelity Brokerage Services LLC on 11/26/2025.

How large is the planned Form 144 sale relative to Agilent (A) shares outstanding?

The notice states that the issuer had 283,500,427 shares of common stock outstanding, while the planned Form 144 sale covers 3,000 shares, giving a sense of the sale’s relative size.

How were the Agilent (A) shares in the Form 144 acquired?

The shares were acquired between 10/31/2022 and 11/22/2024 through a mix of ESPP purchases for cash and restricted stock vesting received as compensation from the issuer.

Which broker will handle the Form 144 sale for Agilent (A) shares?

The planned sale of 3,000 Agilent common shares will be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, on the NYSE.

What representation does the seller make in this Agilent (A) Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as part of signing the notice.

Over what period were the restricted stock awards and ESPP shares for Agilent (A) obtained?

The table shows acquisitions of common stock from 10/31/2022 (ESPP purchase) through 11/22/2024 (restricted stock vesting), reflecting ongoing equity compensation and ESPP participation.